YB2 Stock Overview
An investment holding company, engages in lottery business in the People’s Republic of China and Hong Kong.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Sinopharm Tech Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.014 |
52 Week High | HK$0.018 |
52 Week Low | HK$0.01 |
Beta | 1.18 |
11 Month Change | -26.09% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 12.40% |
Recent News & Updates
Recent updates
Shareholder Returns
YB2 | DE Hospitality | DE Market | |
---|---|---|---|
7D | 0% | 5.5% | 0.6% |
1Y | n/a | 36.3% | 11.8% |
Return vs Industry: Insufficient data to determine how YB2 performed against the German Hospitality industry.
Return vs Market: Insufficient data to determine how YB2 performed against the German Market.
Price Volatility
YB2 volatility | |
---|---|
YB2 Average Weekly Movement | n/a |
Hospitality Industry Average Movement | 4.8% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.7% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: YB2's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine YB2's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 19 | n/a | www.sinopharmtech.com.hk |
Sinopharm Tech Holdings Limited, an investment holding company, engages in lottery business in the People’s Republic of China and Hong Kong. It operates through Provision of Lottery-Related Services, Provision of Internet Plus Services, and Manufacturing and Distribution of Personal Protective Equipment segments. The company offers lottery-related hardware and software systems.
Sinopharm Tech Holdings Limited Fundamentals Summary
YB2 fundamental statistics | |
---|---|
Market cap | €3.21m |
Earnings (TTM) | -€1.28m |
Revenue (TTM) | €5.16m |
0.6x
P/S Ratio-2.4x
P/E RatioIs YB2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
YB2 income statement (TTM) | |
---|---|
Revenue | HK$42.84m |
Cost of Revenue | HK$37.37m |
Gross Profit | HK$5.47m |
Other Expenses | HK$16.11m |
Earnings | -HK$10.63m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.058 |
Gross Margin | 12.77% |
Net Profit Margin | -24.83% |
Debt/Equity Ratio | 0% |
How did YB2 perform over the long term?
See historical performance and comparison